Exposureefficacy and safety analysis of trastuzumab deruxtecan (T-DXd) in patients with advanced/metastatic HER2+breast cancer (BC): Analyses from Phase 3 Studies DESTINYBreast02 (DB-02) and DESTINYBreast03 (DB-03)

被引：0
作者：
Li, Claire
Wada, Russ
Li, Hanbin
Kastrissios, Helen
Abutarif, Malaz
Garimella, Tushar
Khatri, Amit
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO3-04-02
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO3-04-02
引用
收藏
页数：3
相关论文
共 1 条
[1]   Exposure-Response Relationships in Patients With HER2-Positive Metastatic Breast Cancer and Other Solid Tumors Treated With Trastuzumab Deruxtecan [J].
Yin, Ophelia ;
Iwata, Hiroji ;
Lin, Chia-Chi ;
Tamura, Kenji ;
Watanabe, Junichiro ;
Wada, Russ ;
Kastrissios, Helen ;
AbuTarif, Malaz ;
Garimella, Tushar ;
Lee, Caleb ;
Zhang, Lin ;
Shahidi, Javad ;
LaCreta, Frank .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 110 (04) :986-996
1